Zuranolone: First Oral Medication FDA Approved for Postpartum Depression

On Aug 4, 2023: Biogen announced the FDA approval of ZURZUVAE™ (Zuranolone) for Women with Postpartum Depression. This is the first oral medication approved for this indication. This approval is based on the results of two phase 3 clinical trials where the improvement in depression was seen as early as Day 3 with sustained effect to Day 45.
Read the post here: psychiatryeducationforum.com/...